Nosocomial Acinetobacter baumannii infections and changing Antibiotic Resistance
Yazarlar (7)
İsmail Necati Hakyemez Bezm-İ Âlem Vakıf Üniversitesi, Türkiye
Abdulkadir Küçükbayrak
Abant İzzet Baysal Üniversitesi, Türkiye
Tekin Taş Abant İzzet Baysal Üniversitesi, Türkiye
Aslıhan Burcu Yıkılgan Turgut Özal Üniversitesi, Türkiye
Akcan Akkaya Abant İzzet Baysal Üniversitesi, Türkiye
Aliye Yaşayacak
Prof. Dr. Hayrettin Akdeniz Abant İzzet Baysal Üniversitesi, Türkiye
Devamını Göster...
Makale Türü Açık Erişim Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Pakistan Journal of Medical Sciences (Q4)
Dergi ISSN 1681-715X Dergi Bilgileri (2013)
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 10-2013
Kabul Tarihi – Yayınlanma Tarihi 29-08-2013
Cilt / Sayı / Sayfa 29 / 5 / 1245–1248 DOI 10.12669/pjms.295.3885
Makale Linki http://pjms.com.pk/index.php/pjms/article/view/3885
UAK Araştırma Alanları
Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji
Özet
Objectives: In the intensive care setting, Acinetobacter baumannii causes ventilator-associated pneumonia and other nosocomial infections that are difficult to treat. Objective of this study was to investigate nosocomial A. baumannii infections and its changing antibiotic resistance.Methods: A total of 56 patients diagnosed with A.baumannii infections between January 2009 and December 2011 were included in the study. Diagnosis for nosocomial infections was established according to the CDC (Centers for Disease Control and Prevention) criteria. Identification of the agents isolated was carried out using conventional methods and VITEK 2 automated system, while antibiotic sensitivity testing was performed through VITEK 2 AST-N090 automated system.Results: The most common infection was nosocomial pneumonia by 43%, among which 46% were ventilator-associated pneumonia. Considering all years, the most effective antibiotics on the isolated strains were found as colistin, tigecycline, imipenem and meropenem. However resistance to imipenem and meropenem was observed to increase over years.Conclusion: The issue of increased resistance to antibiotics poses difficulty in treatment of A. baumannii infections which in turn increases the rate of mortality and cost. In order to prevent development of resistance, antibiotics must be used in an appropriate way in accompanied with proper guidance.doi: http://dx.doi.org/10.12669/pjms.295.3885How to cite this:Hakyemez IN, Kucukbayrak A, Tas T, Yikilgan AB, Akkaya A, Yasayacak A, et al. Nosocomial Acinetobacter baumannii infections and changing Antibiotic Resistance. Pak J Med Sci 2013;29(5):1245-1248.
Anahtar Kelimeler
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Yöksis 14
Nosocomial Acinetobacter baumannii infections and changing Antibiotic Resistance